About Cyto Pulse Sciences, Inc.
Cyto Pulse Sciences was acquired by Cellectis in September, 2010 and is no longer in operation. It was a clinical-stage medical device and treatment development company dedicated to advancing quality of life through novel electric field based technologies for oncology, gene therapy and infectious disease applications. Cyto Pulse's IP portfolio primarily focused on in vivo DNA vaccine delivery systems, tools for mAb discovery research, and large-scale cell transfection for GMP production environments. Specialties Commercial and clinical electroporation & electrofusion technology
Cyto Pulse Sciences, Inc. Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X